Vartan E. Ghazarossian
Vorstandsvorsitzender bei Amaros Medical, Inc.
Profil
Vartan E.
Ghazarossian founded Biometric Imaging, Inc. in 1991, where he worked as Research Director in 1993 and Vascular Therapeutics, Inc. in 1994, where he worked as Vice President-Technology Development in 1999.
Dr. Ghazarossian also founded Visant Medical, Inc., where he is working as Chief Executive Officer from 2017.
Dr. Ghazarossian also currently works at Amaros Medical, Inc., as President, Chief Executive Officer & Director and Amaros, Inc., as Chief Executive Officer.
Dr. Ghazarossian also formerly worked at FlowMedica, Inc., as President & Chief Executive Officer, StemCor Systems, Inc., as President & Chief Executive Officer, Neurofluidics, Inc., as President & Chief Executive Officer, VasoStitch, Inc., as President & Chief Executive Officer, Imetrx, Inc., as President & Chief Executive Officer, Molecular Devices LLC, as Program Manager in 1991, and Ablative Solutions, Inc., as President & Chief Operating Officer.
Dr. Ghazarossian received his doctorate degree from the University of Wisconsin.
Aktive Positionen von Vartan E. Ghazarossian
| Unternehmen | Position | Beginn |
|---|---|---|
Amaros Medical, Inc.
 Amaros Medical, Inc. Medical SpecialtiesHealth Technology Amaros Medical, Inc. provides health care services. The company is headquartered in Menlo Park, CA. | Vorstandsvorsitzender | - |
Amaros, Inc.
 Amaros, Inc. Packaged SoftwareTechnology Services Amaros, Inc. develops artificial intelligence for clinical development and post-market monitoring of therapeutics. The CEO of the American company is Vartan E. Ghazarossian. | Vorstandsvorsitzender | - |
Visant Medical, Inc.
 Visant Medical, Inc. Medical/Nursing ServicesHealth Services Part of Amring Pharmaceuticals, Inc., Visant Medical, Inc. is a clinical-stage medical device company based in Menlo Park, CA. Symatese SAS, a French company based in Lyon, was instrumental in the development of Lacrifill, significantly enhancing the product's design and performance, by leveraging its expertise in tissue regeneration, reconstruction, and related delivery systems. The company received FDA 510 (k) clearance in 2022 for Lacrifill® cross-linked hyaluronic acid-based canalicular occlusive device, which is intended to block tear drainage by occlusion of the canalicular system. The device is indicated for use, for up to 6 months, in patients experiencing dry eye symptoms. The company specializes in injectable crosslinked HA gels for many markets, including aesthetic, rheumatology, and ophthalmology. Symatese designs the most advanced medical device solutions thanks to their technology portfolio in hyaluronic acid, collagen, thermoplastics, and silicone. The company was founded by Cary J. Reich and Vartan E. Ghazarossian. Vartan E. Ghazarossian has been the CEO since incorporation. Visant Medical was acquired by Amring Pharmaceuticals, Inc. on December 18, 2023. | Vorstandsvorsitzender | 01.08.2017 |
Ehemalige bekannte Positionen von Vartan E. Ghazarossian
| Unternehmen | Position | Ende |
|---|---|---|
StemCor Systems, Inc.
 StemCor Systems, Inc. Medical SpecialtiesHealth Technology StemCor Systems, Inc. develops proprietary and minimally-invasive bone marrow collection systems for regenerative medicine. Its products include MarrowMiner System and MarrowSelect. The company was founded in June 2003 by Daniel Kraft and is headquartered in Menlo Park, CA. | Vorstandsvorsitzender | 28.09.2011 |
Vascular Therapeutics, Inc.
 Vascular Therapeutics, Inc. Pharmaceuticals: OtherHealth Technology Vascular Therapeutics, Inc. develops glycol therapeutics for cardiovascular diseases. The firm also discovers and develops therapeutic agents to prevent & treat life-threatening blood clotting disorders. It serves cardiovascular diseases such as acute myocardial infarction, stroke, pulmonary embolism and deep vein thrombosis. The company was founded in July, 1994 and is headquartered in Mountain View, CA. | Gründer | 01.01.1999 |
Biometric Imaging, Inc.
 Biometric Imaging, Inc. Medical SpecialtiesHealth Technology Biometric Imaging, Inc. manufactures cellular analysis instruments. It offers services to clinics, hospitals, blood banks, and cancer management centers for disease management and therapy monitoring. The company was founded by Bala S. Manian in 1992 and is headquartered in Mountain View, CA. | Gründer | 01.01.1993 |
Molecular Devices LLC
 Molecular Devices LLC Medical SpecialtiesHealth Technology Molecular Devices LLC engages in the provision of bioanalytical solutions for protein and cell biology in life science research, pharmaceutical, and bio-therapeutic development. Its product portfolio includes platforms for screening, genomic and cellular analysis, colony selection, and microplate detection. The company was founded by Harden M. McConnell in July, 1983 and is headquartered in San Jose, CA. | Corporate Officer/Principal | 01.01.1991 |
| Imetrx, Inc. | Vorstandsvorsitzender | - |
Ausbildung von Vartan E. Ghazarossian
| University of Wisconsin | Doctorate Degree |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Private Unternehmen | 12 |
|---|---|
Molecular Devices LLC
Molecular Devices LLC Medical SpecialtiesHealth Technology Molecular Devices LLC engages in the provision of bioanalytical solutions for protein and cell biology in life science research, pharmaceutical, and bio-therapeutic development. Its product portfolio includes platforms for screening, genomic and cellular analysis, colony selection, and microplate detection. The company was founded by Harden M. McConnell in July, 1983 and is headquartered in San Jose, CA. | Health Technology |
FlowMedica, Inc.
 FlowMedica, Inc. Medical SpecialtiesHealth Technology FlowMedica, Inc. develops intravascular systems and medical devices. The company's products include Benephit CV, PVSolo, PVMini, and XT Infusion systems. It also develops novel, proprietary, and minimally invasive intravascular systems for implementing Targeted Renal Therapy. The company was founded in 2002 and is headquartered in Fremont, CA. | Health Technology |
StemCor Systems, Inc.
StemCor Systems, Inc. Medical SpecialtiesHealth Technology StemCor Systems, Inc. develops proprietary and minimally-invasive bone marrow collection systems for regenerative medicine. Its products include MarrowMiner System and MarrowSelect. The company was founded in June 2003 by Daniel Kraft and is headquartered in Menlo Park, CA. | Health Technology |
Ablative Solutions, Inc.
 Ablative Solutions, Inc. Medical SpecialtiesHealth Technology Ablative Solutions, Inc. develops and markets endovascular catheters for the treatment of hypertension. It offers solutions for heart failure, kidney disease, metabolic syndrome, and sleep apnea. The company was founded by Tim A. Fischell and David R. Fischell in 2011 and is headquartered in San Jose, CA. | Health Technology |
Biometric Imaging, Inc.
Biometric Imaging, Inc. Medical SpecialtiesHealth Technology Biometric Imaging, Inc. manufactures cellular analysis instruments. It offers services to clinics, hospitals, blood banks, and cancer management centers for disease management and therapy monitoring. The company was founded by Bala S. Manian in 1992 and is headquartered in Mountain View, CA. | Health Technology |
Vascular Therapeutics, Inc.
Vascular Therapeutics, Inc. Pharmaceuticals: OtherHealth Technology Vascular Therapeutics, Inc. develops glycol therapeutics for cardiovascular diseases. The firm also discovers and develops therapeutic agents to prevent & treat life-threatening blood clotting disorders. It serves cardiovascular diseases such as acute myocardial infarction, stroke, pulmonary embolism and deep vein thrombosis. The company was founded in July, 1994 and is headquartered in Mountain View, CA. | Health Technology |
Neurofluidics, Inc.
 Neurofluidics, Inc. Medical DistributorsDistribution Services Neurofluidics, Inc. develops neurological therapies. It also develops targeted and logical treatment approaches for patients suffering from neurological disorders. The company was founded in 2008 and is headquartered in Menlo Park, CA. | Distribution Services |
| VasoStitch, Inc. | Health Technology |
| Imetrx, Inc. | |
Amaros Medical, Inc.
Amaros Medical, Inc. Medical SpecialtiesHealth Technology Amaros Medical, Inc. provides health care services. The company is headquartered in Menlo Park, CA. | Health Technology |
Amaros, Inc.
Amaros, Inc. Packaged SoftwareTechnology Services Amaros, Inc. develops artificial intelligence for clinical development and post-market monitoring of therapeutics. The CEO of the American company is Vartan E. Ghazarossian. | Technology Services |
Visant Medical, Inc.
Visant Medical, Inc. Medical/Nursing ServicesHealth Services Part of Amring Pharmaceuticals, Inc., Visant Medical, Inc. is a clinical-stage medical device company based in Menlo Park, CA. Symatese SAS, a French company based in Lyon, was instrumental in the development of Lacrifill, significantly enhancing the product's design and performance, by leveraging its expertise in tissue regeneration, reconstruction, and related delivery systems. The company received FDA 510 (k) clearance in 2022 for Lacrifill® cross-linked hyaluronic acid-based canalicular occlusive device, which is intended to block tear drainage by occlusion of the canalicular system. The device is indicated for use, for up to 6 months, in patients experiencing dry eye symptoms. The company specializes in injectable crosslinked HA gels for many markets, including aesthetic, rheumatology, and ophthalmology. Symatese designs the most advanced medical device solutions thanks to their technology portfolio in hyaluronic acid, collagen, thermoplastics, and silicone. The company was founded by Cary J. Reich and Vartan E. Ghazarossian. Vartan E. Ghazarossian has been the CEO since incorporation. Visant Medical was acquired by Amring Pharmaceuticals, Inc. on December 18, 2023. | Health Services |
